Marker Therapeutics (MRKR) PT Lowered to $8 at Roth Capital After Investment Conference Presentation
Tweet Send to a Friend
Roth Capital analyst Tony Butler lowered the price target on Marker Therapeutics (NASDAQ: MRKR) to $8.00 (from $10.00) after the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
